Company Filing History:
2 out of 70 
1 out of 2 Years Active: 2007-2012
Title: Innovations of Ricardo De La C Silva Rodriguez
Introduction
Ricardo De La C Silva Rodriguez is a notable inventor based in Ciudad de la Habana, Cuba. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric proteins aimed at combating viral infections. With a total of 3 patents, his work has the potential to impact the pharmaceutical industry positively.
Latest Patents
One of his latest patents involves the creation of chimeric proteins that induce effects directed against viruses. This invention focuses on obtaining chimeric chains that code for proteins capable of inducing a serotype-specific and protective humoral immune response against Dengue virus infections. The innovative aspect of this invention lies in its ability to eliminate the effects of serotype-nonspecific viral immunoenhancement, which can lead to severe clinical complications. The chimeric chains consist of a specific combination of fragments from a mutated protein with dehydrogenase activity and regions coding for the envelope (E) protein of the Dengue virus. When these components are inserted into an expression vector, they produce chimeric proteins with unique properties. The resultant chimeric molecules are applicable in the pharmaceutical industry for developing vaccine preparations and diagnostic tools with high serotype specificity for human use.
Career Highlights
Throughout his career, Ricardo has worked with esteemed institutions such as the Centro de Ingeniería Genética y Biotecnología. His expertise in genetic engineering and biotechnology has allowed him to contribute significantly to advancements in vaccine development and viral diagnostics.
Collaborations
Ricardo has collaborated with notable colleagues, including Lisset Hermida Cruz and Rayner Rodriguez Diaz. These partnerships have further enhanced his research and development efforts in the field of biotechnology.
Conclusion
Ricardo De La C Silva Rodriguez is a prominent inventor whose work in chimeric proteins has the potential to revolutionize vaccine development against viral infections. His contributions to biotechnology are noteworthy and reflect his commitment to advancing public health.